Vani Gandhi, MD
Basic profileVani Gandhi is an Infectious Disease physician affiliated with Icahn School of Medicine at Mount Sinai. OpenAlex indexes 11 publications with 296 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year20253 payments$65
- Gilead Sciences, Inc.Program year20241 payment$119
- ViiV Healthcare CompanyProgram year20211 payment$21
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
26.2%Statin7.7%Atorvastatin Calcium68%Pravastatin Sodium17%Rosuvastatin Calcium12%Livalo2%Lovastatin2%Part D<11 patientsCalcium channel blocker5%Amlodipine Besylate73%Nifedipine Er24%Diltiazem 24hr Er (Cd)3%Part D<11 patients+ 15 more classes in this area
Anti-infectives
24.4%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor6.7%Tivicay44%Juluca37%Isentress11%Dovato8%Part D<11 patientsProtease Inhibitor5.9%Prezcobix39%Ritonavir16%Evotaz14%Prezista11%Atazanavir Sulfate7%Darunavir6%Symtuza4%Lopinavir-Ritonavir3%Part D<11 patients+ 12 more classes in this area
Nervous system
14.1%Gabapentinoids3.3%Gabapentin85%Pregabalin15%Part D<11 patientsOpioid Agonist2.7%Oxycodone Hcl35%Oxycodone-Acetaminophen30%Tramadol Hcl13%Methadone Hcl12%Endocet11%Part D<11 patients+ 15 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Severe Mpox Among People With Advanced Human Immunodeficiency Virus Receiving Prolonged Tecovirimat in New York City
Open Forum Infectious Diseases
2024 - Severe Monkeypox in Hospitalized Patients — United States, August 10–October 10, 2022
MMWR Morbidity and Mortality Weekly Report
2022 - THE BURDEN OF CORONARY ARTERY DISEASE IN THOSE WITH HUMAN IMMUNODEFICIENCY VIRUS AS DEMONSTRATED BY NEED FOR PERCUTANEOUS CORONARY INTERVENTION
Journal of the American College of Cardiology
2017 - Human Immunodeficiency Virus Medicine Association Pain Management Guidelines Needed to Curb Opioid Epidemic
Clinical Infectious Diseases
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Gregg Stone, MD
Icahn School of Medicine at Mount Sinai
Jonathan Halperin, MD
Icahn School of Medicine at Mount Sinai
Dennis Charney, MD
Icahn School of Medicine at Mount Sinai
Thomas Walsh, MD
Cornell University
Douglas Richman, MD
University of California San Diego
Henry Masur, MD
National Institutes of Health
Vance Fowler, MD
Duke University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”